Glucose-sensing neurons respond to glucose or its metabolite that act as a signaling cue to regulate their neuronal activity. According to the glucostatic hypothesis proposed in 1953, feeding and related behaviors are regulated by neurons in the brain that sense changes in glucose levels in the blood^[@R1]^. Despite of the discovery of glucose-sensing neurons in the hypothalamus through electrophysiological methods eleven years later^[@R2]^, the physiological role of these neurons remained unclear^[@R3],[@R4]^, however, until recently, when a population of glucose-excited neurons in the *Drosophila* brain were determined to function as an internal nutrient sensor to mediate the animal's consumption of sugar^[@R5]^. A large number of glucose-sensing neurons appear to be present in animals^[@R6]^; we speculated that these neurons mediate physiological functions that are critical for the wellbeing of the animal, including glucose homeostasis. We report herein the discovery of a pair of glucose-excited neurons in the *Drosophila* brain that maintain glucose homeostasis by coordinating the activity of the two key hormones involved in that process: insulin and glucagon.

*CN* neurons project to the PI and CC {#S1}
=====================================

In our search for neurons that respond to sugar according to its nutritional value, we used a two-choice assay^[@R7]^ to screen *Vienna tiles (VT)-Gal4* lines^[@R8]^ that had been crossed to *UAS-Kir2.1, tub-Gal80*^*ts*^ flies for defects in their ability to select nutritive D-glucose over nonnutritive L-glucose ([Extended Data Fig.1 a](#F6){ref-type="fig"}, see [Methods](#S9){ref-type="sec"}). We isolated two independent Gal4 lines, *VT58471-* and *VT43147-Gal4,* that failed to select D-glucose after periods of starvation and appeared to contain identical dorsolateral cells that are labeled by *corazonin (Crz)-Gal4* line^[@R9]^ ([Extended Data Fig.1b](#F6){ref-type="fig"}-[c](#F6){ref-type="fig"}, arrowheads). Flies in which *Crz-Gal4* expressing neurons had been inactivated failed to select D-glucose even when starved [(Extended Data Fig.1d)](#F6){ref-type="fig"}. These results suggest that the dorsolateral neurons labeled by the Crz and two candidate Gal4 lines mediate the behavioral response to sugar.

We used anti-Crz antibody to confirm the identity of the dorsolateral neurons ([Fig. 1a](#F1){ref-type="fig"}, upper right). A previous study demonstrated that a subset of Crz-expressing neurons also express sNPF^[@R10]^. Immuno-labeling revealed that the dorsolateral neurons expressing Crz also express sNPF ([Fig. 1a](#F1){ref-type="fig"}, lower right). In the light of these findings, we named these *CN (Crz*^*+*^*, sNPF*^*+*^*)* neurons. To restrict Gal4 expression to few cells that include the dorsolateral neurons, we crossed *VT58471-Gal4* to *cholinergic-Gal80,* named *CN-Gal4,* which illustrated unambiguous labeling of a pair of *CN* neurons when crossed to *UAS-mCD8:GFP* ([Fig. 1a](#F1){ref-type="fig"}, left-arrowheads). Flies in which these dorsolateral neurons were inactivated using *CN-Gal4* failed to select D-glucose when starved ([Fig. 1b](#F1){ref-type="fig"}). A *CN* cell body projects an axon that bifurcates to form two major branches ([Fig. 1a](#F1){ref-type="fig"}). One branch (axon 1) projects to the pars intercerebralis (PI) region of the brain and the other branch (axon 2) projects ventrolaterally toward the CC^[@R11],[@R12]^ ([Fig. 1a](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"}, and [Extended Data Fig. 2a](#F7){ref-type="fig"}). We used an intersectional approach to define these projections further, thereby validating that axon 1 innervates the PI and axon 2 projects to the CC (Fig. 1d and Extended Data Fig. 2b, c, see [Methods](#S9){ref-type="sec"}). We also used this approach to induce the expression of tetanus toxin (TNT)^[@R13]^ to silence a pair of *CN* neurons. These flies failed to choose D-glucose even after starvation when *CN* neurons were inactivated ([Fig. 1e](#F1){ref-type="fig"}, see [Methods](#S9){ref-type="sec"}). This provided more evidence of the contribution of the pair of the dorsolateral *CN* neurons to glucose-evoked behavior.

*CN* neurons are glucose-excited {#S2}
================================

We next sought to determine whether *CN* neurons respond to glucose and other sugars. Calcium imaging studies using *ex vivo* brain preparations of flies carrying the calcium indicator *UAS-GCaMP6s*^[@R14]^ and *CN-Gal4* revealed that *CN* neurons were robustly activated by D-glucose with substantial calcium oscillations ([Fig. 2a](#F2){ref-type="fig"}-[c](#F2){ref-type="fig"} and [Extended Data Fig. 3a](#F8){ref-type="fig"}-[e](#F8){ref-type="fig"}). *CN* neurons also responded to D-trehalose and D-fructose, which are found in the hemolymph, but failed to respond to (1) nonnutritive sugar, L-glucose ([Fig. 2b](#F2){ref-type="fig"}, [d](#F2){ref-type="fig"}); (2) non-hemolymph sugar, sucrose; (3) non-sugar nutrients, amino acids ([Extended Data Fig. 3f](#F8){ref-type="fig"}-[j](#F8){ref-type="fig"}). D-glucose and D-trehalose are key sugars in the hemolymph, although D-trehalose stimulates the activity of *CN* neurons only after a substantial delay (−12 min), possibly because it requires additional metabolic steps to produce glucose from trehalose. d-fructose at 20 mM activated *CN* neurons, even though the concentration of D-fructose in the hemolymph is much lower (\< 2 mM)^[@R15]^. These findings suggest that the pair of *CN* neurons only respond to D-glucose under normal physiological conditions.

We next determined whether activation of *CN* neurons by D-glucose requires glucose metabolism inside the cell. Exposing the brain to D-glucose mixed with 2-D-deoxy-glucose (2DG), phlorizin, or nimodipine, which inhibits glycolysis, glucose transporter, or voltage-gated calcium channel, respectively, blunted the glucose-induced stimulation of *CN* neurons ([Fig. 2b](#F2){ref-type="fig"}, [d](#F2){ref-type="fig"}). In the presence of pyruvate (an end product of glycolysis), the *CN* neurons demonstrated activity similar to that seen in the presence of other hemolymph sugars ([Extended Data Fig. 3f](#F8){ref-type="fig"}-[j](#F8){ref-type="fig"}). An application of ATP-sensitive potassium (K~ATP~)^[@R16]^ channel blocker, glibenclamide^[@R17]^, resulted in activation of *CN* neurons ([Fig. 2b](#F2){ref-type="fig"}-[c](#F2){ref-type="fig"}). Furthermore, glucose-induced calcium transients of these neurons were not abrogated by the application of a sodium-channel blocker, tetrodotoxin (TTX) ([Fig. 2b](#F2){ref-type="fig"}). We also determined using RNAi lines that *glucose transporter 1 (Glutl), hexokinase C (Hex-C),* a subunit of K~ATP~ channel *(SUR1),* and voltage-gated calcium channel are required in *CN* neurons for the two-choice behavior ([Extended Data Fig. 4a](#F9){ref-type="fig"}-[c](#F9){ref-type="fig"}). Consistent with the behavioral results, glucose-induced calcium response of *CN* neurons requires *Glutl, SUR1,* and a voltage-gated calcium channel ([Extended Data Fig. 4d](#F9){ref-type="fig"}-[h](#F9){ref-type="fig"}), further substantiating the role of the intracellular glucose metabolic pathway in stimulating *CN* neuronal activity.

We next used the calcium-dependent nuclear import of LexA (CaLexA) system^[@R18]^ to measure cellular activity in *CN* neurons in intact flies, and found that GFP signal driven by the CaLexA system in starved flies was significantly reduced compared to the signal in fed flies, and the signal was restored when starved flies were refed D-glucose ([Fig. 2e](#F2){ref-type="fig"}-[g](#F2){ref-type="fig"} and [Extended Data Fig. 4i](#F9){ref-type="fig"}-[j](#F9){ref-type="fig"}). These results suggest that the activity of *CN* neurons in live animals is stimulated by the increase in glucose levels observed under fed conditions. In addition to the altered CaLexA signals, we evaluated the effect of glucose on the number and intensity of synaptotagmin (Syt)^[@R19]^-GPF^+^ puncta in starved and refed animals. In starved animals, these parameters were decreased significantly in axon 1; after they were refed D-glucose, the parameters were restored to normal levels ([Fig. 3a](#F3){ref-type="fig"}-[b](#F3){ref-type="fig"} and [Extended Data Fig. 5a](#F10){ref-type="fig"}, [c](#F10){ref-type="fig"}). This nutrient-dependent plasticity, however, was not observed in *Crz-Gal4-labeled* axonal processes that did not originate from the dorsolateral *CN* neurons ([Extended Data Fig. 5e](#F10){ref-type="fig"}-[h](#F10){ref-type="fig"}).

*CN* neurons promote dilp2 release from IPC {#S3}
===========================================

We next sought to determine whether *CN* neurons are coupled with I PCs^[@R20]^ at the synaptic level. To this end, we used a modified GFP Reconstitution Across Synaptic Partners (GRASP) method^[@R21]^ and found that the GRASP signals were visible around the synapse between *CN* neurons and IPCs ([Fig. 3c](#F3){ref-type="fig"}). This indicates the presence of physical coupling between *CN* neurons and IPCs.

To determine whether the coupling between *CN* neurons and IPCs is functional, we expressed ATP-gated P2X~2~ receptors^[@R22]^ in *CN* neurons and GCaMP6s^[@R14]^ in IPCs, and then stimulated *CN* neurons using ATP while recording from the IPCs. As shown in [Fig. 3d](#F3){ref-type="fig"}, ATP-induced *CN* neuronal activity was accompanied by a significant increase in the amplitude of GCaMP6 signals in the IPCs in fed flies; this effect was reduced in starved flies ([Fig. 3d](#F3){ref-type="fig"} and [Extended Data Fig. 6a](#F11){ref-type="fig"}-[b](#F11){ref-type="fig"}). This finding supports the hypothesis that the nutrient-dependent synaptic changes observed between *CN* neurons and IPCs indeed have functional consequences. The *CN* neurons did not appear to be functionally coupled to glucose-excited Dh44 neurons^[@R5]^ ([Extended Data Fig. 6c](#F11){ref-type="fig"}-[f](#F11){ref-type="fig"}). Furthermore, we investigated whether *CN* neuronal activity is required for dilp2 secretion from IPCs. We observed a significant reduction in the intensity of dilp2 immunoreactivity in the IPCs of fed control flies, but not in fed flies in which *CN* neurons had been inactivated ([Fig. 3e](#F3){ref-type="fig"}). These results suggest that an excitatory signal from the *CN* neurons is important for the secretion of dilp2 from IPCs in response to increased glucose levels. Using mass spectrometry and dot blot assay, we further validated that the flies carrying *CN-Gal4* and *UAS-Kir2.1* had lower dilp2 levels circulating in hemolymph in contrast to the higher dilp2 levels found in IPCs ([Fig. 3f](#F3){ref-type="fig"} and [Extended Data Fig. 7a](#F12){ref-type="fig"}-[c](#F12){ref-type="fig"}, [e](#F12){ref-type="fig"}-[f](#F12){ref-type="fig"}).

To further clarify the role of *CN* neurons in mediating glucose-evoked activity in IPCs, we inactivated *CN* neurons by expressing TNT^[@R13]^ and then examined the responsiveness of IPCs to glucose. Remarkably, the amplitude of calcium signals in IPCs that had been exposed to D-glucose was significantly reduced when the *CN* neurons were inactivated ([Fig. 3g](#F3){ref-type="fig"}). Furthermore, we found that IPCs harbor at least three sub-populations of neurons with distinct responses to glucose or K~ATP~ channel blocker ([Fig. 3h](#F3){ref-type="fig"} and [Extended Data Fig. 8a](#F13){ref-type="fig"}-[f](#F13){ref-type="fig"}). These findings suggest that *CN* neuronal activity is required for the majority of IPCs to respond to glucose.

*CN* neurons inhibit AKH secretion from CC {#S4}
==========================================

To determine whether nutrient-dependent plasticity also occurs in axon 2 of the *CN* neurons, we monitored the number and intensity of Syt-GFP^+^ puncta before and after feeding flies with D-glucose. We observed a significant reduction in these parameters in starved flies and a restoration to normal levels after refeeding starved flies D-glucose ([Fig. 4a](#F4){ref-type="fig"}-[b](#F4){ref-type="fig"} and [Extended Data Fig. 5b](#F10){ref-type="fig"}, [d](#F10){ref-type="fig"}). This raised a possibility of coupling between *CN* neurons and AKH-producing cells. Using a modified GRASP method^[@R23]^, we observed notable GRASP fluorescent signals around AKH-producing cells ([Fig. 4c](#F4){ref-type="fig"}). To determine whether there is any functional connectivity between these cells, we activated the *CN* neurons while monitoring the activity of AKH-producing cells and found that calcium transients in the AKH-producing cells appeared to decrease during *CN* neuronal activation ([Fig. 4d](#F4){ref-type="fig"}).

To probe this observation further, we expressed the Arclight receptor^[@R24]^, which increases fluorescent signals when cells become hyperpolarized, in AKH-producing cells and P2X~2~ receptors in *CN* neurons. When the *CN* neurons were activated using ATP, the Arclight fluorescent intensity in fed flies increased significantly compared to that in starved flies ([Fig. 4e](#F4){ref-type="fig"}), validating that nutrient-dependent changes occurred in the synapses between *CN* neurons and AKH-producing cells. Notably, when *CN* neurons were inactivated, the intracellular AKH levels decreased significantly compared with controls ([Fig. 4f](#F4){ref-type="fig"}). Using mass spectrometry and dot blot assay, we confirmed significantly higher levels of AKH in hemolymph of flies carrying *CN-Gal4* and *UAS-Kir2.1* compared with those in control flies ([Fig. 4g](#F4){ref-type="fig"} and [Extended Data Fig. 7d](#F12){ref-type="fig"}, [g](#F12){ref-type="fig"}-[h](#F12){ref-type="fig"}). These findings suggest that *CN* neuronal activity inhibits the release of AKH from the CC, and the increase of AKH levels in hemolymph.

sNPF is the functional neurotransmitter {#S5}
=======================================

We next inquired which neurotransmitter(s) in axon 1 and axon 2 are important for regulating the functionally opposing synaptic activities. We tested the role for Crz and sNPF in the two-choice behavior using RNAi lines and found that *sNPF* in *CN* neurons and *sNPF* receptor in the postsynaptic IPCs, but not *Crz* or its receptor, are important ([Fig. 5a](#F5){ref-type="fig"}-[b](#F5){ref-type="fig"} and [Extended Data Fig. 9a](#F14){ref-type="fig"}-[d](#F14){ref-type="fig"}). We also found that sNPF, but not Crz, in *CN* neurons was significantly reduced when *CN* neurons were exposed to D-glucose ([Fig. 5c](#F5){ref-type="fig"} and [Extended Data Fig. 9e](#F14){ref-type="fig"}). We observed that approximately a half of the IPCs that had responded to glucose failed to respond glucose when the dominate negative allele of *sNPF* receptor^[@R25]^ was expressed in IPCs ([Fig. 5d](#F5){ref-type="fig"} and [Extended Data Fig. 8g](#F13){ref-type="fig"}-[i](#F13){ref-type="fig"}). Furthermore, we observed that intracellular AKH levels remained high in AKH-producing cells in fed control flies, but declined significantly in fed flies in which the function of *sNPF* receptor^[@R25]^ was inhibited in AKH-producing cells ([Fig. 5e](#F5){ref-type="fig"}).

Finally, we determined whether sNPF alters IPCs or/and CC activity. The activity of IPCs was stimulated substantially by the application of sNPF ([Extended Data Fig. 10a](#F15){ref-type="fig"}-[b](#F15){ref-type="fig"})^[@R26]^, whereas the CC activity was significantly inhibited by sNPF ([Fig. 5f](#F5){ref-type="fig"}). These functionally opposing effects of sNPF are mediated likely by Gq in IPCs and Gi/o in AKH-producing cells through sNPF receptor, which is a G protein coupled receptor^[@R27]^. Exposing the brain to U73122, a PLC inhibitor that inhibits the Gq pathway, eliminated the glucose-evoked activation of IPCs, but had no effect on sNPF-induced inhibition of AKH-expressing cells ([Fig. 5f](#F5){ref-type="fig"}-[g](#F5){ref-type="fig"}). Conversely, exposing the brain to pertussis toxin, a Gi inhibitor, blunted the sNPF-induced inhibition of AKH-producing cells, but had no effect on the glucose-evoked activation of IPCs ([Fig. 5f](#F5){ref-type="fig"}-[g](#F5){ref-type="fig"}). These results indicated that axon 1 and axon 2 can have opposing synaptic activities through a mechanism involving the same neurotransmitter and receptor but with distinct downstream factors coupled with opposing outputs.

To determine whether *CN* neuronal activity can alter circulating sugar levels in flies, we monitored circulating concentrations of glucose and trehalose in hemolymph, and found that they were significantly increased in flies in which *CN* neurons were inactivated compared with controls ([Fig. 5h](#F5){ref-type="fig"} and [Extended Data Fig. 10c](#F15){ref-type="fig"}). This finding illustrates that dysfunctional *CN* neuronal input to IPCs and AKH-producing cells results in a defect in glucose homeostasis.

Discussion {#S6}
==========

We identified and characterized a pair of glucose-sensing neurons in the *Drosophila* brain that play an essential role in maintaining glucose homeostasis. This was achieved by counterbalancing the activities of *Drosophila* equivalents of insulin-and glucagon-producing cells. When food consumption leads to a rise in hemolymph sugar levels, *CN* neurons excite the IPCs through sNPF and its receptor, which appear to be coupled to the Gq signaling cascade to induce the secretion of dilp2, while suppressing the release of AKH by using the same sNPF receptor, but is coupled with Gi signaling pathway ([Fig. 5i](#F5){ref-type="fig"} and [Extended Data Fig. 10d](#F15){ref-type="fig"}). We speculate that precise control of these opposing functions is further possible because the accompanied nutrient-dependent plastic changes arise from a single cell.

This study represents the discovery of how the activity of the two key endocrine systems is coordinated in metazoans and that their coordination is under the direct control of glucose-sensing neurons. It has been speculated that such coordination may be carried out in mammals through the sympathetic and parasympathetic nerves that connect the pancreatic islets with glucose-sensing neurons in the hypothalamus and hindbrain^[@R28]^. The finding that a large proportion of IPCs respond to glucose through *CN* neurons in insects raises an intriguing possibility that both direct and indirect mechanisms control endocrine function in mammals^[@R29],[@R30]^. Finally, this work may shed light on the function of glucose-sensing neurons and further research is needed to understand how these regulatory processes are affected by excessive nutrition and other metabolic disturbances, including obesity.

Methods {#S7}
=======

Fly strains {#S8}
-----------

Flies were raised on standard cornmeal-molasses food (940 mL water, 9 g agar, 15 g yeast, 36 g cornmeal, 36 mL molasses, 1.12 g tegosept, 3.8 mL propionic acid, total 1 L of fly food) at 23 °C with 12/12 hours light-dark cycles. Fly strains were obtained as described in [Supplementary Table 2](#SD5){ref-type="supplementary-material"}. All the lines used for behavioral testing were backcrossed into *w*^*1118*^ (Bloomington \#6326) background for at least 5 generations.

Two-choice assay {#S9}
----------------

The two-choice preference assay was performed as previously described^[@R7]^. Briefly, approximately 30--40 male flies (1--3 days old) were collected under CO~2~ anesthesia and allowed to recover for 2--3 more days. The flies were starved in an empty vial with wetted Kimwipe with 2--3 mL of distilled water for 5 hours (fed condition) or 24 hours (starved condition). They were introduced into a two-choice arena containing two food sources, 50 mM D-glucose and 200 mM L-glucose, that were colored with a tasteless food dye (1 *%* of red food dye and 0.7 % of green food dye, McCORMICK) where flies were allowed to feed for 2 hours in the dark. The majority of the flies preferred the sweeter L-glucose (200 mM) when fed, but chose nutritive D-glucose (50 mM) when starved^[@R5],[@R7]^. For experiments using *UAS-Kir2.1, tub-Gal80*^*ts*^, flies were raised at 18 °C before transferring to 30 °C for 48--72 hours to inactivate Gal80 in order to express Kir2.1. Following behavioral testing was conducted at 23 °C. For experiments using flies that do not bear *tub-Gal80*^ts^, behavioral testing was conducted at 23 °C. All sugars (D-glucose, D-trehalose, and D-fructose) were purchased from Sigma except L-glucose (Carbosynth). Statistical analyses were performed using GraphPad Prism 8.1.1. Food preference was scored as a percentage of Preference Index (% PI), calculated as shown below: $$\%\text{PI} = \frac{\left. \text{(\#~flies~ate~food~1~+~0}.5.\#\text{flies\ ate\ both} \right) - \left( \left( \#\text{flies\ ate\ food}2 + 0.5.\#\text{flies\ ate\ both} \right) \right.}{(\text{Total}\#\text{flies\ ate})} \times 100$$

Two-choice behavioral screening using Vienna Tiles (VT)-Gal4 drives {#S10}
-------------------------------------------------------------------

We ordered over 100 Gal4 drives from the Vienna *Drosophila* RNAi Center (VDRC, Vienna Tiles (VT)-library)^[@R8]^ for the screening. We conducted two-choice assay screening using 95 VT-Gal4 drivers, which were crossed with *UAS-Kir2.1, tub-Gal80*^*ts*^ (inward-rectifier potassium ion channel allele, Kir2.1, with *tubulin-*[*t*]{.ul}*emperature* [s]{.ul}*ensitive Gal80).* Then we found 18 candidate Gal4 drivers, which prefer L-glucose more when they were starved, and inspected the expression pattern of each Gal4 driver. Among those candidates, we narrowed down two Gal4 drivers, VT58471 and VT43147, because a pair of neurons in dorsal-lateral area in the brain were clearly overlapped in those two candidate Gal4 drivers.

Intersectional approach to define *CN* neurons in a single cell resolution {#S11}
--------------------------------------------------------------------------

To define *CN* neurons in a single cell resolution, we combined LexA-driven flippase *(LexAop-FLP)* with *UAS-FRT-stop-FRT-effector* to limit the expression of effector in the areas in which Gal4 and LexA lines overlap. This induced the expression of *UAS-FRT-stop-FRT-smGFP*^[@R31]^, under the control of *CN-Gal4* and another independent *R20F11-LexA* line. *R20F11-LexA* also labels *CN* neurons and exhibited a defect when crossed to *LexAop-TNT (tetanus toxin)* in the two-choice assay. We also used this approach to induce the expression of UAS*-FRT-stop-FRT-TNT,* under the control of *CN-Gal4* and *R20F11-LexA,* to silence a pair of *CN* neurons.

Immunostaining {#S12}
--------------

Immunohistochemistry of the brain, the ventral nerve cord (VNC), corpora cardiaca (CC), and the foregut was conducted as previously described^[@R5]^. Briefly, the brains were dissected in PBS (1.86 mM NaH2PO4, 8.41 mM Na2HPO4, 175 mM NaCl) and fixed in 4 *%* paraformaldehyde (PFA)/PBS for 30 min at 23 °C. After washing in PBST (PBS + 0.3 % Triton X-100, Invitrogen) (3 times, 10 min each), the brains were blocked in 10 % normal goat serum (NGS, Jackson Immunoresearch, T-005--000-121)/PBST for 1 hour at 23 °C, and then incubated with primary antibodies for 12--48 hours at 4 °C. After washing in PBST (3 times, 10 min each), the sample brains were incubated with secondary antibodies for 12--24 hours at 4 °C and washed again using PBST (3 times, 10 min each). The primary antibodies used as follows: chicken anti-GFP (1:500; Invitrogen, A10262), rabbit anti-GFP (1:500; Invitrogen, A-11122), mouse anti-GFP (1:100; Sigma, G6539, use for synaptobrevin-GRASP), mouse anti-nc82 (1:25; Development Studies Hybridoma Bank, DSHB, AB-2314866), rabbit anti-dsRed (1:500; Clontech, 632496), rabbit anti-corazonin (Crz) (1:500; a gift from Jan Veenstra, Université de Bordeaux, France), rabbit anti-sNPF (1:500; a gift from Jan Veenstra, Université de Bordeaux, France), rabbit anti-dilp2 (1:500; a gift from Ernst Hafen, Institute for Molecular Systems Biology, Zürich, Switzerland), and rabbit anti-AKH (1:500; gifts from Jae H. Park, University of Tennessee, Knoxville, TN, and Seung K. Kim, Stanford University, CA) antibodies. Secondary antibodies used as follows: Alexa Fluor 633 goat anti-rabbit IgG (1:500; Invitrogen, A-21070), Alexa Fluor 555 goat anti-mouse IgG (1:500; Invitrogen, A-21127), Alexa Fluor 555 goat anti-rabbit IgG (1:500; Invitrogen, A27039), Alexa Fluor 488 goat anti-rabbit IgG (1:500; Invitrogen, A27034), Alexa Fluor 488 goat anti-mouse IgG (1:500; Invitrogen), and Alexa Fluor 488 goat anti-chicken IgG (1:500; Invitrogen, A28175). We used Vectashield (Vector Labs, H1000) for mounting the samples. All Images were acquired using a Zeiss LSM 800 confocal microscope (Zeiss) with 25X lens at a 1,024 X 1,024 resolution. Z-stacked images were constructed using ZEN image analyzing software (Carl Zeiss, ZEN 2.3 SP1 FP1, version: 14.0.12.201). Quantifications and statistical analyses were conducted using ImageJ and GraphPad Prism 8.1.1, respectively.

*Ex vivo* GCaMP and Arclight imaging {#S13}
------------------------------------

*Ex vivo* calcium imaging using GCaMP6s was performed as described^[@R5]^. Adult male fly brains or corpora cardiaca (CC) cells in the foregut were dissected with artificial hemolymph-like solution (AHL: 108 mM NaCl, 8.2 mM MgCl2, 4 mM NaHCO3,1 mM NaH2PO4, 2 mM CaCl2, 5 mM KCl, 5 mM HEPES, appropriate amount of sucrose to balance osmolarity, the pH was adjusted to 7.3 with 1 M NaOH) and were immobilized by tissue holder (Warner Instruments) on a Sylgard-based perfusion chamber. Sugars (D-glucose, D-trehalose, D-fructose, and sucrose), 2-D-deoxy-glucose, phlorizin, pyruvate, and L-essential amino acids (1 X L-(10)-EAAs: 0.6 mM L-Arg, 0.2 mM L-His, 0.4 mM L-Ile, 0.4 mM L-Leu, 0.4 mM L-Lys, 0.1 mM L-Met, 0.2 mM L-Phe, 0.4 mM L-Thr, 0.05 mM L-Trp, and 0.4 mM L-Val) were purchased from Sigma. Tetanus toxin (TTX), glibenclamide, and nimodipine were purchased from Tocris. We mixed 20 mM D-glucose contained AHL with 0.5 μM TTX, 20 mM 2-D-deoxy-glucose, 1 mM phlorizin, or 5 μM nimodipine. The concentrations of TTX, glibenclamide, 2-D-deoxy-glucose, phlorizin, nimodipine, sucrose, pyruvate, and L-essential amino acids (1 X L-(10)-EAAs) that were used in the experiments were determined based on the pilot experiments. *Ex vivo* Arclight imaging was performed as previously described with a modification^[@R32]^. Each brain was recorded for 200--500 frames in total (512 X 512 pixels; each frame, 5 sec). After imaging, the condition of the cells was checked by treating 80 mM KCl contained AHL solution. Exchange of different solutions was automatically controlled by a ValveBank controller (AutoMate Scientific). Changes in fluorescent intensity were recorded using a Prairie two-photon microscope and Prairie view software v4.3.2.18 (Prairie Technologies Inc.) with a 40X water immersion lens (Olympus). All Image analyses were conducted using ImageJ. A region of interest (ROI) was centered using StackReg plugin in ImageJ.

Peak amplitude (% ΔF/F) was obtained by subtracting the amplitude of prestimulation baseline (average of 30 frames, 1 frame = 5 sec) from the stimulation-evoked peak amplitude. Oscillation number refers to the total number of calcium oscillations during stimulation. Duration is the length of calcium response during stimulation. Oscillation frequency is a ratio of oscillation numbers/duration. Max ΔF/F (%) = ((F~max~-F~0~)/F~0~)\*100; F~max~, maximum fluorescence observed during stimulation; F~0~, average fluorescence of 30 baseline slides. Min ΔF/F (%) = ((Fmin-F~0~)/F~0~)\*100; F~min~, minimum fluorescence observed during stimulation. Max ΔF/F (%) was used when we calculated the increasing amount of fluorescent signal of cells during stimulation and Min ΔF/F (%) was used when we calculated the decreasing amount of fluorescent signal of cells during stimulation. Min ΔF/F (%) was only used in [Fig. 4d](#F4){ref-type="fig"}. Statistical analyses were conducted with GraphPad Prism 8.1.1.

*In vivo* GCaMP imaging {#S14}
-----------------------

*In vivo* calcium imaging using GCaMP6s was modified from the previous study^[@R33]^. Adult male flies were collected (1--2 days old) and recovered in standard fly food for two more days. They were then fixed on the Sylgard-based perfusion chamber using Epoxy resin (Devcon) and their head cuticles were removed to make a window in order to conduct *in vivo* calcium imaging. Other procedures are similar with those of *ex vivo* calcium imaging.

CaLexA measurement {#S15}
------------------

Adult male flies carrying *Crz-Gal4* (or *CN-Gal4)* and *CaLexA (UAS-mLexA-VP16-NFAT, LexAop-GFP)* were collected 1--2 days after eclosion and recovered for 2--3 more days in standard fly food at 23 °C. A group of flies were dissected and their brains were fixed with *4%* PFA/PBS fixation for 20 min without antibody staining (fed flies). Another group of flies after 24 hours of starvation (wet starvation) were dissected and their brains were fixed similarly (starved flies). We refed some of the starved flies with 200 mM D-glucose (with 1 % agar) for 24 hours and their brains were fixed similarly (refed flies). Native CaLexA-driven GFP signals were captured using confocal microscopy (LSM800, Zeiss, 25X lens). The brains were co-stained with anti-Crz antibody. The intensity of CaLexA-driven GFP signal was normalized by the intensity of anti-Crz staining in *CN* neurons. The CaLexA-driven GFP signal was measured and normalized using corrected total fluorescence (CTF) method^[@R34]^, calculated by subtracting the background endogenous fluorescence from the integrated GFP signal of an area of interest. Z-stacked images were constructed using ZEN software (Zeiss) and analyzed using ImageJ.

Measurement of nutrient-dependent plasticity {#S16}
--------------------------------------------

To measure nutrient-dependent plasticity of *CN* axons and presynaptic terminals, adult male flies carrying *Crz-Gal4* (or *CN-Gal4)* and *UAS-synaptotagmin (Syt)-GFP* were collected 1--2 days after eclosion and recovered for 2--3 more days in standard fly food at 23°C. A group of flies were dissected and their brains were stained by using anti-GFP antibody (fed flies). Another group of flies after 24 hours of starvation (wet starvation) were dissected and their brains were stained similarly (starved flies). We refed some of the starved flies with 200 mM D-glucose (with 1 *%* agar) for 24 hours and their brains were stained similarly (refed flies). We measured and quantified the number of Syt-GFP^+^ puncta and the length of axons as described in previous study^[@R35]^. The intensity of Syt-GFP signal was measured and normalized using corrected total fluorescence (CTF) method^[@R34]^, calculated by subtracting the background endogenous fluorescence from the integrated GFP signal of an area of interest. Images were captured by Zeiss LSM 800 confocal microscopy (Zeiss) and were analyzed using ImageJ. Statistical analyses were conducted with GraphPad Prism 8.1.1.

GRASP analysis {#S17}
--------------

In [Fig. 3c](#F3){ref-type="fig"}, experimental flies carrying *CN-Gal4, UAS-Neurexin (Nrx)-sGFP1--10, R20F11-LexA,* and *LexAop-CD4-sGFP11* and control flies carrying *CN-Gal4, UAS-Neurexin (Nrx)-sGFP1--10,* and *LexAop-CD4-sGFP11* were used to examine the physical connectivity between *CN* neurons and IPCs. We expressed one component of the split-GFP with the presynaptic marker, neurexin, in the *CN* neurons and another component in the IPCs. In [Fig. 4c](#F4){ref-type="fig"}, experimental flies carrying *R20F11-LexA, LexAop-Synaptobrevin (Syb)-GFP1--10, AKH-Gal4,* and *UAS-CD4GFP11* and control flies carrying *R20F11-LexA, LexAop-Syb-GFP1--10,* and *UAS-CD4-GFP11* were used to examine the physical connectivity between *CN* neurons and AKH-producing cells. We expressed one component of the split-GFP with the presynaptic marker, synaptobrevin, in the *CN* neurons and another component in the AKH-producing cells. To measure native GRASP-induced GFP signals, adult male flies were collected 3--5 days after eclosion and their brains were dissected in ice-cold PBS and fixed in 4 % PFA/PBS for 20 min at 23 °C and washed in PBST (3 times, 10 min each). Then the brains were mounted in Vectashield medium (Vector Labs, H1000) without an antibody staining. To measure the synaptobrevin-GRASP^23^-induced GFP signals, adult male flies were collected 3--5 days after eclosion and their brains were dissected in PBS and fixed in 4 % PFA/PBS for 30 min at 23 °C. These brains were then blocked using 10 % NGS/PBST (1 hour at 23 °C), and washed in PBST (3 times, 10 min each) before subsequent immune-labeling with mouse anti-GFP antibody to probe GFP signals as previously described^[@R23]^. The brains were mounted in Vectashield medium (Vector Labs, H1000) after finishing the primary and secondary antibody staining processes.

Functional connectivity using P2X~2~ system {#S18}
-------------------------------------------

1\) Experimental flies carrying *dilp2-LexA, LexAop-GCaMP6s, CN-Gal4, and UAS-P2X*~*2*~ and control flies carrying *dilp2-LexA, LexAop-GCaMP6s, and UAS-P2X*~*2*~ were used to examine the functional connectivity between *CN* neurons and IPCs. 2) Experimental flies harboring *R20F11-LexA, LexAop-P2X*~*2*~*, AKH-Gal4, and UAS-GCaMP6s* and control flies bearing *LexAop-P2X*~*2*~*, AKH-Gal4, and UAS-GCaMP6s,* and experimental flies carrying *R20F11-LexA, LexAop-P2X*~*2*~*, AKH-Gal4, and UAS-Arclight* and control flies harboring *LexAop-P2X*~*2*~*, AKH-Gal4, and UAS-Arclight* were used to examine the functional connectivity between *CN* neurons and AKH-producing cells. To clarify the nutrient dependent changes in synapse between *CN* neurons and IPCs, and between *CN* neurons and AKH-producing cells, we used normal fly food fed experimental flies, 24-hour-starved (wet starvation) experimental flies, or normal fly food fed control flies. We applied 2.5 mM ATP (Sigma, A26209) for 50 seconds (10 slides, 5 sec in each slide) in AHL saline to excite P2X~2~ receptor expressing cells. Changes in fluorescent intensity were recorded using a Prairie two-photon microscope with a 40X water immersion lens (Olympus). Image analyses were conducted using ImageJ. A region of interest (ROI) was centered using StackReg plugin in ImageJ. Plotting graphs and statistical analyses were conducted with GraphPad Prism 8.1.1.

Dilp2 and AKH secretion assay {#S19}
-----------------------------

To measure dilp2 secretion/retention, adult male flies (1--3 days old) were collected under CO~2~ anesthesia and allowed to recover for 2--3 more days in standard fly food. A group of flies were starved with water (wet starvation) for 24 hours. Their brains were dissected and stained using anti-dilp2 antibody. Some of the starved flies were refed with 200 mM D-glucose (with 1 % agar) for 24 hours, and their brains were dissected and stained using anti-dilp2 antibody. All the processes were conducted at 23 °C. To measure AKH secretion/retention, adult male flies (1--3 days old) were collected under CO~2~ anesthesia and allowed to recover for 2--3 more days in standard fly food. Their brains were dissected and stained using anti-AKH antibody as described. The analysis of Z-stacked images was performed using ZEN software (Zeiss) and ImageJ.

Quantitation of *Drosophila* insulin-like peptide 2 (dilp2) and adipokinetic hormone (AKH) by Parallel Reaction Monitoring (PRM) mass spectrometry {#S20}
--------------------------------------------------------------------------------------------------------------------------------------------------

Hemolymph of 500--600 flies that were fed with standard fly food was collected and pooled as previously described^[@R36]^. Dilp2 and AKH were extracted from the control *(UAS-Kir2.1/+)* and experimental *(UAS-Kir2.1/CN-Gal4, CN* silenced) samples using two volumes of cold ethanol following as a previously described method with modification^[@R37]^; 100 μL of hemolymph was mixed with 200 μL of ice cold ethanol (Fisher Scientific, 90 % ethyl alcohol (v/v) with 5 % isopropanol and 5 % methanol) and incubated at −20 °C for 30 min, then centrifuged at 15,000 X *g* for 20 min. Supernatants were carefully removed and dried to a small droplet by vacuum centrifugation. Extracts were solubilized in 100 μL of 100 mM ammonium bicarbonate and disulfide bonds reduced with 500 mM dithiothreitol to a final concentration of 10 mM DTT for 1 hour at 37 °C. Cysteines were alkylated with iodoacetamide (200 mM) to a final concentration of 40 mM at 37 °C for 1 hour in the dark. Excess iodoacetamide was quenched by adding DTT to a final concentration of 40 mM with incubation for 30 min, in the dark, at room temperature. Samples were each digested with 800 ng-1 μg of Trypsin (Trypsin Gold, Mass Spectrometry Grade, Promega) overnight, and after acidification with 10 *%* formic acid (final concentration of 0.5--1 *%* formic acid), resulting peptides were desalted using hand packed reversed phase Empore C18 Extraction Disks (3M, St. Paul, MN, USA) using a previously described method^[@R38]^. Desalted peptides were concentrated to a small droplet by vacuum centrifugation and reconstituted in 10 μL 0.1 % formic acid in water. 10 % of the peptide material was used for data-dependent-acquisition (DDA) and 50 % used for targeted parallel reaction monitoring (PRM) liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). A Q Exactive HF mass spectrometer was coupled directly to an EASY-nLC 1000 (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a self-packed 75 μm x 20 cm reverse phase column (ReproSil-Pur C18, 3 μM, Dr. Maisch GmbH, Germany) for peptide separation. Analytical column temperature was maintained at 50 °C by a column oven (Sonation GmBH, Germany). Peptides were eluted with a 3--40 % acetonitrile gradient over 110 min at a flow rate of 250 nL/min. For DDA, the mass spectrometer was operated in DDA mode with survey scans acquired at a resolution of 120,000 (at m/z 200) over a scan range of 300--1750 m/z. Up to 15 most abundant precursors from the survey scan were selected with an isolation window of 1.6 Th and fragmented by higher-energy collisional dissociation with normalized collision energy (NCE) of 27. The maximum injection time for the survey and MS/MS scans was 60 ms and the ion target value (AGC) for both scan modes was set to 3e6. For PRM analysis, 1 full MS scan was acquired at 60,000 resolution followed by MS/MS of 9 target precursor m/z loaded as the inclusion list. Each PRM target peptide was analyzed at resolution 15,000 with isolation window of 1.4 Th. The ion target value was set to 5e5.

Mass spectrometry data processing. {#S21}
----------------------------------

RAW files generated from the DDA experiments were analyzed by MaxQuant proteomics software^[@R39]^ (version 1.5.7.0) using a *Drosophila* fasta (19,694 entries) database. Files from PRM experiments were analyzed with Thermo Scientific Xcalibur (version 4.1.31.9) software. Layouts containing target precursor and fragment masses were created with a mass accuracy set to 5 ppm. At specific events when MS1 and MS/MS fragments were aligned, the intensity of each specific precursor and fragment were extracted and noted. Additional confirmation of the analysis was carried out using Skyline (version 4.10.18169) Proteomics software^[@R40]^. Ion intensity extraction and alignment of spectra were visually inspected and confirmed in each case. Processed intensities of dilp2 B chain, AKH, and those fragment ions were normalized by the estimated total protein level (top 3 precursor intensity of top 99 proteins) in the hemolymph. Normalization of precursor peptide and fragment intensities were done by analyzing the DDA spectra from each set of replicate control and experimental samples by MaxQuant label-free quantitative analysis; intensities of top three peptides from proteins found in both samples were summed and compared (see [Supplementary Table 3](#SD5){ref-type="supplementary-material"}). The nomenclature for peptide fragmentation during mass spectrometry was described in previous studies^[@R41],[@R42]^.

Note: We also performed several experiments using methanol to extract peptides from the hemolymph^[@R43]^. The dilp2 and AKH quantitation results from those PRM experiments were consistent with results obtained using the ethanol extracted materials presented in this manuscript, but contained additional contaminants that interfered with liquid chromatography (data not shown).

Dot blot assay {#S22}
--------------

Hemolymph of 60--80 flies that were fed with standard fly food was collected as previously described^[@R36]^. The total protein in the hemolymph was measured by Bradford (Bio-Rad) and the concentration is adjusted to 1 mg/mL in PBS^[@R44]^. 10 μL of hemolymph was dropped on 0.2 μm nitrocellulose membrane (GE Healthcare, Uppsala, CA, USA) and left at room temperature until to be dried. The membrane was then boiled in PBS for 3 min and subsequently fixed in 4 *%* PFA/PBS for another 20 min. The membrane was blocked with 3% bovine serum albumin (BSA) in PBS for 1 hour at room temperature (21 °C) and then incubated with mouse anti-HA (1:500; Covance, 901501) antibody or purified rabbit anti-AKH antibody (1:500; a gift from Seung K. Kim, Stanford University, CA.) in 3 % BSA/PBS at 4 °C for overnight followed by incubation with HRP-conjugated secondary antibodies in 3 % BSA/PBS for 1 hour at room temperature (21 °C). *P*~*dilp2*~*-dilp2-HA*^[@R36]^ line was used for detecting dilp2 in the hemolymph. The membrane was developed using Chemidoc M (Bio-Rad, Hercules, CA, USA). The black dots intensity was considered the levels of dilp2 and AKH in flies. Ponceau staining was utilized as loading control. The quantification and analysis of dot blot results were conducted using Fiji software and GraphPad Prism 8.1.1, respectively. For gel source data, see [Supplementary Figure 1](#SD5){ref-type="supplementary-material"}.

Measurement of intracellular sNPF and Crz levels in *CN* neurons {#S23}
----------------------------------------------------------------

Intracellular sNPF and Crz levels after incubating with sugars were measured as previously described^[@R5]^. The brains of 18-hour-starved flies in which *UAS-mCD8:GFP* was expressed in the Crz-expressing neurons *(Crz-Gal4 \> UAS-mCD8:GFP)* were dissected in cold AHL (sugar free), incubated in 80 mM sucrose (AHL), 80 mM D-glucose (D-Glc), 80 mM D-glucose mixed with 0.5 μM TTX (D-Glc/TTX), or 80 mM L-glucose (L-Glc) contained AHL for 30 min and then fixed with 4 % PFA/PBS and stained with anti-sNPF or anti-Crz antibodies as described earlier. All Images were acquired using a Zeiss LSM 800 confocal microscope (Zeiss) with 25X lens at a 1,024 X 1,024 resolution. Z-stacked images were constructed using ZEN image analyzing software (Zeiss). Quantifications and statistical analyses were conducted using ImageJ and GraphPad Prism 8.1.1, respectively.

Classification of the IPCs into three sub-populations {#S24}
-----------------------------------------------------

When Max ΔF/F (%) of a cell is higher than 50 *%* of average Max ΔF/F (%) of control brains, we counted the cell as an "activated" cell by the stimulation. We classified the IPCs into "activated" or "inactivated" cells after treating D-glucose or K~ATP~ channel blocker with or without the function of *CN* neurons or *sNPF* receptor in IPCs. Using this calculation, we categorized IPCs into three sub-populations. In [Fig. 3h](#F3){ref-type="fig"}, 74.42 % of IPCs (32/43 cells) in control flies carrying *R20F11-LexA, dilp2-Gal4,* and *UAS-GCaMP6s* responded to D-glucose, whereas 25.58 % of the IPCs (1¼3 cells) failed to respond to D-glucose. 20.69 % of IPCs (12/58 cells) responded to D-glucose in experimental flies carrying *R20F11-LexA, LexAop-TNT, dilp2-Gal4,* and *UAS-GCaMP6s,* whereas 53.73 % of the IPCs failed to respond to glucose. In [Extended Data Fig. 8d](#F13){ref-type="fig"}, 71.43 % of IPCs (20/28 cells) in control flies carrying *R20F11-LexA, dilp2-Gal4,* and *UAS-GCaMP6s* responded to glibenclamide, whereas 28.57 % of the IPCs (8/28 cells) failed to respond to glibenclamide. 23.08 % of IPCs (9/39 cells) in experimental flies carrying *R20F11-LexA, LexAop-TNT, dilp2-Gal4,* and *UAS-GCaMP6s* responded to glibenclamide, whereas 48.35 % of the IPCs failed to respond to glibenclamide. In [Extended Data Fig. 8g](#F13){ref-type="fig"}, 75.68 % of IPCs (28/37 cells) in control flies carrying *dilp2-Gal4* and *UAS-GCaMP6s* responded to D-glucose, whereas 24.32 % of the IPCs (9/37 cells) failed to respond. 27.27 % of IPCs (9/33 cells) responded to D-glucose in experimental flies carrying *dilp2-Gal4, UAS-sNPFR-DN,* and *UAS-GCaMP6s,* whereas 48.41 % of the IPCs failed to respond.

sNPF neuropeptide treatment to the IPCs and CC {#S25}
----------------------------------------------

sNPF neuropeptide was administrated to IPCs and CC using a modified method from a previous study^[@R26]^. sNPF was purchased from Thermo Fisher Scientific (sequence: AQRSPSLRLRF, purity \> 95 %, unmodified). We made 50 mM stock solution of sNPF in DMSO (Sigma, D2650) and keep it at −80 °C. Pertussis toxin (Tocris, 3097), U73122 (Tocris, 1268), or U73343 (Tocris, 4133) was mixed with D-glucose or sNPF and treated to IPCs in the brain or AKH-producing cells in CC. We mixed 80 μM sNPF or 20 mM [d-]{.smallcaps}glucose contained AHL with 1 ng/μL pertussis toxin (PT), 1 μM U73122, or 1 μM U73343 (a non-functional enantiomer of U73122). The concentrations of PT, U73122, and U73343 that were used in the experiments were determined based on the pilot experiments.

Hemolymph glycemia measurement {#S26}
------------------------------

Hemolymph glucose and trehalose levels were measured as previously described^[@R5]^. Briefly, 30--40 flies starved with water for 24 hours (starved) or fed with standard fly food (fed) were decapitated and their hemolymph was collected with a capillary pipette (0.25 μL Microcaps, Drummond). 0.25 μL of the hemolymph was mixed with 50 μL of Glucose (HK) Assay Kit (Sigma, GAHK20) and incubated for 20 min at 23 °C, and then measured the absorbance at 340 nm using a Nanodrop spectrophotometer (Thermo Scientific). To measure trehalose concentrations in the hemolymph, pig kidney trehalase (1:500, Sigma, T8778) was added to the mixture of Glucose Assay Kit and incubated for 16--20 hours at 37 °C, and then measured the absorbance at 340 nm. Standard curves (D-glucose and D-trehalose) were generated for each trial. Plotting graphs and statistical analyses were conducted with GraphPad Prism 8.1.1.

Statistics and reproducibility {#S27}
------------------------------

All statistical analyses were conducted with GraphPad Prism 8.1.1 (provided by NYU School of Medicine). For comparing two normally distributed groups, unpaired two-tailed t tests were used. For multiple comparisons between normally distributed groups, oneway ANOVAs followed by Tukey's post hoc test were used (see [Supplementary Table 1](#SD5){ref-type="supplementary-material"}). Without an asterisk means non-significant (*P* \> *0.05).* The statistical analyses presented in this manuscript were assisted by a statistics expert (Dr. Xiaochun Li) in NYU. For the two-choice behavioral data (Figs. [1b](#F1){ref-type="fig"}, [e](#F1){ref-type="fig"}, [5a](#F5){ref-type="fig"}, [b](#F5){ref-type="fig"}, [Extended Data Figs. 1a](#F6){ref-type="fig"}, [d](#F6){ref-type="fig"}, [2c](#F7){ref-type="fig"}, [4a](#F9){ref-type="fig"}-[c](#F9){ref-type="fig"}), each data point (dot) represents a biological replicate bearing 30\~40 male flies for a trial. For *ex vivo* imaging data using GCaMP6s or Arclight (Figs. [2c](#F2){ref-type="fig"}, [d](#F2){ref-type="fig"}, [3d](#F3){ref-type="fig"}, [g](#F3){ref-type="fig"}, [4d](#F4){ref-type="fig"}, [e](#F4){ref-type="fig"}, [5d](#F5){ref-type="fig"}, [f](#F5){ref-type="fig"}, [g](#F5){ref-type="fig"}, [Extended Data Figs. 3b](#F8){ref-type="fig"}-[e](#F8){ref-type="fig"}, [3g](#F8){ref-type="fig"}-[j](#F8){ref-type="fig"}, [4e](#F9){ref-type="fig"}-[h](#F9){ref-type="fig"}, [6b](#F11){ref-type="fig"}, [8c](#F13){ref-type="fig"}, [10b](#F15){ref-type="fig"}), each data point (dot) represents a biological replicate of maximum or minimum amplitudes of ΔF/F (%) during the experimental period. In [Extended Data Fig. 6c](#F11){ref-type="fig"}-[f](#F11){ref-type="fig"}, each average trace contains at least three biological replicates. For confocal fluorescent image of the brains or CCs stained with antibodies (Figs. [2e](#F2){ref-type="fig"}-[g](#F2){ref-type="fig"}, [3a](#F3){ref-type="fig"}, [b](#F3){ref-type="fig"}, [c](#F3){ref-type="fig"}, [e](#F3){ref-type="fig"}, [4a](#F4){ref-type="fig"}, [b](#F4){ref-type="fig"}, [c](#F4){ref-type="fig"}, [f](#F4){ref-type="fig"}, [5c](#F5){ref-type="fig"}, [e](#F5){ref-type="fig"}, [Extended Data Figs. 4i](#F9){ref-type="fig"}, [j](#F9){ref-type="fig"}, [5](#F10){ref-type="fig"}, [9e](#F14){ref-type="fig"}), we present the exact number of biological replicates in [Supplementary Table 1](#SD5){ref-type="supplementary-material"}. Moreover, the representative images (Figs. [1a](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"}, [d](#F1){ref-type="fig"}, [2a](#F2){ref-type="fig"}, [3c](#F3){ref-type="fig"}, [4c](#F4){ref-type="fig"}, [Extended data Figs. 1c](#F6){ref-type="fig"}, [2a](#F7){ref-type="fig"}, [b](#F7){ref-type="fig"}, [9a](#F14){ref-type="fig"}, [b](#F14){ref-type="fig"}) were independently replicated more than five times. For the mass spectrophotometry and dot blot assay (Figs. [3f](#F3){ref-type="fig"}, [4g](#F4){ref-type="fig"}, [Extended Data Fig. 7g](#F12){ref-type="fig"}-[j](#F12){ref-type="fig"}), each data point (dot) or a trial represents a biological replicate bearing 500\~600 flies for mass spectrophotometry and 60\~80 flies for the dot blot assay. For the two-choice behavioral and *ex vivo* imaging experiments, we repeated more than 3 times based on our pilot experiments. For the behavioral experiments, we did not include two or three independent pilot experiments because the experimental setups were not clearly controlled. However, they had qualitatively similar results; yet, the standard deviations were substantially high.

Extended Data {#S28}
=============

![Identification of neurons that are required for the starvation-induced nutrient selection. **a**, The result of a screen for *Vienna tiles (VT)-Gal4* lines when bearing *UAS-Kir2.1, tub-Gal80*^*ts*^ that failed to select D-glucose after 24 hours of starvation. **b**, Expression patterns of 18 candidate Gal4 lines isolated from the screen. Scale bar, 100 μm. Brain images from FlyLight Gal4/LexA collection are shown. White boxes denote a pair of the dorsolateral cells. **c**, Expression patterns of *VT58471-Gal4 \> UAS-mCD8:GFP* line, *VT43147-Gal4 \> UAS-mCD8:GFP* line, and *Crz-Gal4 \> UAS-mCD8:GFP* line in the brain, the ventral nerve cord (VNC), and a part of the foregut, stained with anti-GFP (green) antibody. Neuropil is stained with nc82 (anti-bruchpilot, magenta) antibody. Cell bodies of candidate neurons (arrowheads) and their projections to the foregut (arrows) are shown. Scale bar, 100 μm. Z-stacked projections are shown. **d**, Inactivation of the candidate neurons by expressing *UAS-Kir2.1, tub-Gal80*^*ts*^ under the control of *VT58471-Gal4, VT43147-Gal4,* or *Crz-Gal4* at 30 °C blunts a preference for D-glucose in starved flies. \*\*\**P* \< 0.001; one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0006){#F6}

![Axons and dendrites of *CN* neurons and a functional LexA line that can label a pair of *CN* neurons. **a**, Axons and dendrites of *CN* neurons in the brain visualized by an axonal marker, *UAS-Syt-eGFP,* and a dendritic marker, *UAS-Denmark,* under the control of *CN-Gal4,* stained with anti-GFP (green) and anti-dsRed (Denmark, magenta) antibodies. Arrowheads denote *CN* cell bodies, and arrows indicates *CN* axons (left) and dendrites (middle). **b**, The brain of a fly carrying *R20F11-LexA* and *LexAop-GFP,* stained with anti-GFP (green) antibody. Cell bodies of *CN* neurons are stained with anti-Crz (magenta) antibody. Arrowheads indicate cell bodies of the dorsolateral *CN* neurons. Scale bar, 20 μm. **c**, Inactivation of *CN* neurons by expressing *LexAop-TNT* under the control of *R20F11-LexA* blunts a preference for D-glucose in starved flies. A1, Axon 1; A2, Axon 2; SEZ, subesophageal zone; PI, pars intercerebralis. Scale bar, 50 μm. Z-stacked projections are shown. \*\*\**P* \< *0.001;* one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0007){#F7}

![The activity of *CN* neurons is stimulated by glucose or pyruvate, but not by sucrose or a mixture of 10 essential amino acids. **a**, Representative traces of *CN* neuronal activity in response to 2 mM, 10 mM, and 15 mM D-glucose. **b-e**, Quantifications of *CN* responses to 1 mM, 2 mM, 5 mM, 10 mM, 15 mM, and 20 mM D-glucose. When 1 to 5 mM D-glucose were applied, all the parameters were increased. When higher concentrations of D-glucose (10 to 20 mM D-glucose) were applied, the oscillation number (**c**) and oscillation frequency (**e**) were decreased while the peak amplitude (**b**) and duration (**d**) were increased. **f**, Representative traces of *CN* neuronal activity in response to 20 mM sucrose, 20 mM pyruvate, and a mixture of 1X L-(10)-essential amino acids (EAAs). **g-j**, Quantifications of *CN* neuronal responses to 20 mM sucrose, 20 mM pyruvate, and a mixture of 1 X L-(10)-EAAs. \**P* \< *0.05, \*\*P \< 0.01;* oneway ANOVA with Tukey post hoc. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0008){#F8}

![*Glucose transporter 1 (Glutl), Hexokinase C (Hex-C),* K~ATP~ channel, and voltage-gated calcium channel are required in *CN* neurons for sensing glucose and the activity of *CN* neuron is determined by the internal energy state in live animals. a, Inactivation of *glucose transporter 1 (Glutl)* by expressing *UAS-Glut1-RNAi* under the control of *CN-Gal4* blunts a preference for D-glucose in starved flies, but not other glucose transporters. **b**, Inactivation of *Hex-C* by expressing *UAS-HexC-RNAi* under the control of *CN-Gal4* blunts a preference for D-glucose in starved flies, but not other hexokinases *(Hex-T2* and *Hex-A).* **c**, Inactivation of K~ATP~ channel or voltage-gated calcium channel by expressing *UAS-SUR1-RNAi* or *UAS-Ca-α1D-RNAi* by *CN-Gal4* blunts a preference for D-glucose in starved flies. **d-h**, Representative traces (**d**) and quantifications (**e-h**) of calcium responses to 1 mM glucose by *CN* neurons of flies in which *glucose transporter 1 (Glutl),* K~ATP~ channel subunit *(SURI),* or voltage-gated calcium channel subunit *(Ca-α1D)* was knocked-down by expressing each RNAi line, or those of control flies. **i-j**, Representative images (**i**) and quantifications of native CaLexA-driven GFP intensity from *Cn* cell bodies (**j**) of fed, starved, or refed flies carrying *CN-Gal4* and *CaLexA (UAS-mLexA-VP16-NFAT, LexAop-GFP).* Cell bodies of *CN* neurons are stained with anti-Crz (magenta) antibody. Scale bar, 20 μm. Z-stacked projections are shown. \**P* \< *0.05, \*\*P \< 0.01, \*\*\*P \< 0.001*; one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0009){#F9}

![Nutrient-dependent plasticity does not occur in neurons other than a pair of the dorsolateral *CN* neurons. **a-d**, The relative fluorescent intensities of Syt-GFP signal (**a, b**) and the branch lengths of (**c, d**) axon 1 (neurite to IPCs, **a, c**) and axon 2 (neurite to CC, **b, d**) in fed, starved, or refed flies carrying *Crz-Ga4* and *UAS-Syt-GFP.* **e-h**, Representative images (**e**) and quantifications (**f-h**) of the number of Syt-GFP^+^ puncta in fed, starved, or refed flies carrying *Crz-Gal4* and *UAS-Syt-GFP* in the dorsal lateral area (DL, **f**), the medial lateral area (ML, **g**), and the subesophageal zone (SEZ, **h**). Arrowheads and arrows indicate Syt-GFP^+^ puncta on axon 1 and axon 2, respectively. Scale bar, 50 μm. Z-stacked projections are shown. \**P* \< *0.05, \*\*P \< 0.01, \*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0010){#F10}

![*CN* neurons expressing P2X~2~ receptor can be readily activated by ATP application and Dh44 neurons and *CN* neurons are not functionally coupled. **a-b**, Average GCaMP traces (**a**) and their ΔF/F (max) quantifications (**b**) of *CN* neurons when exposed to 2.5 mM ATP. **c**, Average GCaMP trace of flies carrying *Dh44-Gal4* and *UAS-GCaMP6s* in response to ATP. **d**, Average GCaMP trace of flies carrying *Dh44-Gal4, UAS-GCaMP6s, Dh44-LexA,* and *LexAop-P2X*~*2*~ in response to ATP. **e**, Average GCaMP trace of flies carrying *Crz-Gal4, UAS-GCaMP6s, Dh44-LexA,* and *LexAop-P2X*~*2*~ in response to ATP. **f**, Average GCaMP trace of flies carrying *Dh44-Gal4, UASGCaMP6s, R20F11-LexA,* and *LexAop-P2X*~*2*~ in response to ATP. *\*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0011){#F11}

![The circulating levels of dilp2 and AKH in hemolymph are measured by mass spectrometry and dot blot assay. **a**, Sequences of dilp2, AKH, tryptic peptide of dilp2 B chain, and tryptic peptide of AKH. We detected dilp2 B chain at m/z (mass to charge ratio): 369.1785 ("TLCSEK", M2H+: 369.1785) and AKH at m/z: 497.2374 ("QLTFSPDW", M2H+: 497.2374). **b**, Nomenclature and m/z values of fragment ions (N-terminal directed "a" and "b" ions, as well as, C-terminal directed "y" ions) which is driven by dilp2 B chain and AKH. **c-d**, Relative extracted ion intensities for the dilp2 B chain and its fragment ions in each trial (**c**), and AKH and its fragment ions in each trial (**d**) generated from the hemolymph of fed flies in which *CN* neurons were inactivated, or those of control flies; see [Methods](#S9){ref-type="sec"}. **e-f**, A dot blot (**e**) and its quantification (**f**) show the levels of dilp2 in the hemolymph of wild type (*w*^*1118*^), *UAS-Kir2.1/CN-Gal4; dilp2-HA,* and *UAS-Kir2.1/+; dilp2-HA* flies, probed with anti-HA antibody to detect dilp2. Because *w*^*1118*^ flies do not express dilp2-HA, they were used as a negative control. **g-h**, A dot blot (**g**) and its quantification (**h**) show the levels of AKH in the hemolymph of *CN-Gal4/+, UAS-Kir2.1/+,* and *UAS-Kir2.1/CN-Gal4* flies, probed with anti-AKH antibody. The intensity of black dots in red dotted circle represents the quantity of dilp2 or AKH level that was later normalized to Ponceau staining. For gel source data, see [Supplementary Figure 1](#SD5){ref-type="supplementary-material"}. \*\**P* \< *0.01, \*\*\*P \< 0.001;* unpaired two-tailed t test for (**f**) and one-way ANOVA with Tukey post hoc test for (**h**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0012){#F12}

![Calcium responses of IPCs to D-glucose or K~ATP~ channel blocker in flies with inactivated *CN* neurons or with non-functional *sNPF* receptor. **a-b**, Individual traces of the IPCs in control flies carrying *R20F11-LexA, dilp2-Gal4,* and *UAS-GCaMP6s* (**a**) and in experimental flies carrying *R20F11-LexA, LexAop-TNT, dilp2-Gal4,* and *UAS-GCaMP6s* (**b**) responding to D-glucose. **c**, Average GCaMP traces and ΔF/F (max) quantifications from the IPCs of fed flies in which *CN* neurons were inactivated by TNT in response to K~ATP~ channel blocker, glibenclamide, or those of control flies. **d**, IPCs comprise three sub-populations according to their response to glibenclamide; see [Methods](#S9){ref-type="sec"}. **e-f**, Individual traces of the IPCs in control flies (**e**) and in flies in which *CN* neurons were inactivated by TNT (**f**) responding to glibenclamide. Because a saturating concentration of D-glucose (20 mM) was used to quantify the populations of IPCs, 100 μM glibenclamide, a saturating concentration for glibenclamide according to our control experiments, was also used. g, IPCs comprise three sub-populations according to their response to glucose with our without sNPF receptor; see [Methods](#S9){ref-type="sec"}. **h-i**, Individual traces of IPCs in control flies (**h**) and in flies in which *sNPF* receptor was rendered non-functional by expressing dominant negative allele of *sNPF* receptor in the IPC (**i**) responding to d-glucose. \*\*\**P* \< *0.001;* unpaired two-tailed t test for (**c**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0013){#F13}

![Crz neuropeptide is not required in *CN* neurons for the two-choice behavior. **a-b**, Expression of Gfp in the brains of the flies carrying *Crz-Gal4* and *UAS-mCD8:GFP* (**a**), or *CrzR (Crz receptor)-Gal4* and *UAS-mCD8:GFP* (**b**). Scale bar, 100 μm. **c-d**, Knock-down of *Crz* or *Crz* receptor in flies carrying *Crz-Gal4* and *UAS-Crz-RNAis* (**c**), or *CrzR-Gal4* and *UAS-CrzR-RNAis* (**d**), respectively, does not eliminate the selection of D-glucose in starved flies. **e**, Immunoreactivity of intracellular Crz in *CN* neurons, probed with anti-Crz antibody, when the brains were incubated in 80 mM sucrose (AHL), 80 mM D-glucose (D-Glc), 80 mM D-glucose mixed with 0.5 μM TTX (D-Glc/TTX), or 80mM L-glucose (L-Glc) contained AHL. Scale bar, 5 μm. Z-stacked projections are shown. One-way ANOVA with Tukey post hoc test for (**c, e**) and unpaired two-tailed t test for (**d**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0014){#F14}

![The activity of IPCs were stimulated by sNPF application and the circulating trehalose level in which *CN* neurons were inactivated was reduced. **a-b**, Average GCaMP traces (**a**) and ΔF/F (max) quantifications (**b**) from the IPCs in response to 80 μM sNPF contained AHL, or those of the DMSO contained AHL. **c**, An increase in circulating trehalose level in fed or starved flies in which *CN* neurons were inactivated. The levels of circulating trehalose in flies carrying *CN-Gal4* and *UAS-Kir2.1* and its heterozygote controls (*CN-Gal4/+* and *UAS-Kir2.1/+*) when they are fed or starved. **d**, A working model of the anatomic connectivities between *CN* neurons and IPCs (green), and between *CN* neurons and AKH-producing cells (red). *CN* neurons regulates glucose homeostasis by counter-balancing the activities of IPCs and AKH-producing cells through sNPF neurotransmitter that activates the IPCs and inactivates the AKH-producing cells. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; unpaired two-tailed t test for (**b**) and one-way ANOVA with Tukey post hoc test for (**c**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0015){#F15}
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![A pair of glucose-sensing neurons in the brain, *CN* neurons, show a unique projection pattern. **a**, *CN* neurons marked by GFP (green) counterstained with nc82 (magenta) antibody in the brain and CC. *CN* neurons (arrowheads) extend their neurites centrally (A1) and ventrolaterally (A2). Asterisks denote unrelated cells labeled by *CN-Gal4.* Scale bar, 50 μm. *CN* cell bodies labeled by GFP (green) co-stained with anti-Crz (magenta, upper right) and anti-sNPF antibodies (magenta, lower right). Scale bar, 5 pm. **b**, Inactivation of *CN* neurons by expressing *UAS-Kir2.1, tub-Gal80*^*ts*^ under the control of *CN-Gal4* at 30 °C blunts a preference for D-glucose in starved flies. **c**, *CN* axons innervate IPCs, stained with anti-dilp2 (magenta) antibody, via A1 (left) and AKH-producing cells, stained with anti-AKH (cyan) antibody, via A2 (right). *CN* axons and dendrites are stained with anti-GFP (green) and anti-dsRed (Denmark, magenta) antibodies, respectively. Scale bar, 20 μm. **d**, Intersectional labeling of *CN* neurons by GFP (green), co-stained with anti-AKH (magenta) antibody. Scale bar, 50 μm. **e**, Intersectional silencing of *CN* neurons blunts a preference for D-glucose in starved flies. Z-stacked projections are shown, except the right panels of (**a**). In this and subsequent figures, all the plots represent mean ± s.e.m. \*\*\**P* \< 0.001; one-way ANOVA with Tukey post hoc test. See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0001){#F1}

![*CN* neurons are activated by nutritive sugars, but not by nonnutritive sugars. **a**, *CN* neurons expressing GCaMP before (middle) and after (right) D-glucose application. Scale bar, 5 μm. **b-d**, Representative traces (**b**) and quantifications (**c-d**) of calcium responses of *CN* neurons to D-glucose (D-glc), D-fructose (D-fru), D-trehalose (D-tre), and glibenclamide (Gliben) (**c**) and L-glucose (L-glc), and D-glucose mixed with 2-D-deoxy-glucose (2DG), phlorizin (Phl), or nimodipine (Nim) (**d**). **e-g**, Representative images revealed by native CaLexA-driven GFP and anti-Crz staining (**e**), and quantifications (**f-g**) of GFP intensity from *CN* cell bodies (**f**) and neurites to IPCs (**g**) of fed, starved, or refed flies carrying Crz-Gal4 and CaLexA; see [Methods](#S9){ref-type="sec"}. Scale bar, 20 μm. Z-stacked projections are shown. \**P* \< *0.05, \*\*P \< 0.01, \*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test. [See Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0002){#F2}

![IPCs' activity and dilp2 secretion require an excitatory signal from *CN* neurons. **a-b**, Representative images (**a**) and quantifications of the number of Syt-GFP^+^ puncta (green) (**b**) in axon 1 (A1) of *CN* neurons in fed, starved, or refed flies carrying *Crz-Gal4* and *UAS-Syt-GFP.* White box denotes *CN* axonal projections to IPCs. **c**, Native GRASP-induced fluorescence (green, arrowheads), co-stained with anti-dilp2 (magenta) antibody. **d**, Average GCaMP traces and ΔF/F (max) quantifications from IPCs of fed or starved flies in which *CN* neurons were stimulated, or those of control fed flies. **e-f**, Relative intensities of dilp2 immunoreactivity in IPCs (**e**) and tryptic peptide of dilp2 B chain from fed hemolymph (**f**) of flies in which *CN* neurons were inactivated, or those of control flies. **g**, Average GCaMP traces and ΔF/F (max) quantifications from IPCs of fed flies in which *CN* neurons were silenced by TNT in response to D-glucose, or those of control flies. **h**, IPCs comprise three sub-populations according to their response to glucose; see [Methods](#S9){ref-type="sec"}. All the scale bars, 20 μm. Z-stacked projections are shown. \*\**P* \< *0.01, \*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test for (**b, d**) and unpaired two-tailed t test for (**e, f, g**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0003){#F3}

![AKH retention in AKH-producing cells requires an inhibitory signal from *CN* neurons. **a-b**, Representatives images stained with anti-GFP and anti-AKH antibodies (**a**) and quantifications of the number of Syt-GFP^+^ puncta (green) (**b**) in axon 2 (A2) of *CN* neurons in fed, starved, or refed flies carrying *Crz-Gal4* and *UAS-Syt-GFP.* Scale bar, 50 μm. **c**, Synaptic GRASP-induced GFP signals (arrowheads) co-stained with anti-AKH (magenta) antibody. Scale bar, 20 μm. **d-e**, Average GCaMP traces and ΔF/F (min) quantifications (**d**), and average Arclight traces and ΔF/F (max) quantifications (**e**) from AKH-producing cells of fed or starved flies in which *CN* neurons were activated, or those of control flies. **f-g**, Relative intensities of AKH immunoreactivity in AKH-producing cells (**f**) and tryptic peptide of AKH from hemolymph (**g**) of fed flies in which *CN* neurons were inactivated, or those of control flies. Scale bar, 20 μm. Z-stacked projections are shown except (**c**). \**P* \< *0.05, \*\*P \< 0.01, \*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test (**b, e, f**) and unpaired two-tailed t test for (**d, g**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0004){#F4}

![sNPF is the functional neurotransmitter of *CN* neurons. **a**, Knock-down of *sNPF* in flies carrying *Crz-Gal4* and *UAS-sNPF-RNAis* abolishes a preference for D-glucose in starved flies. **b**, Expression of *UAS-sNPFR-DN* by *dilp2-Gal4* blunts a preference for D-glucose in starved flies. **c**, Immunoreactivity of intracellular sNPF in *CN* neurons when the brains were incubated in 80 mM sucrose (AHL), D-glucose (D-GIc), D-glucose mixed with 0.5 μM TTX (D-GIc/TTX), or L-glucose (L-GIc). Scale bar, 5 μm. **d**, Average GCaMP traces and ΔF/F (max) quantifications from IPCs of fed flies in which *UAS-sNPFR-DN* was expressed in IPCs in response to D-glucose, or those of control flies. **e**, Immunoreactivity of intracellular AKH in CC of flies carrying *UAS-sNPFR-DN* and *AKH-Gal4,* or those of control flies. Scale bar, 20 μm. **f**, Average Arclight traces and ΔF/F (max) quantifications from CC in response to sNPF mixed with Gi inhibitor, pertussis toxin (PT), or Gq (phospholipase C, PLC) inhibitor, U73122, or the DMSO only controls. **g**, Average GCaMP traces and ΔF/F (max) quantifications from IPCs in response to D-glucose mixed with U73122, PT, or U73343, a non-functional enantiomer of **h**, Circulating glucose levels of flies in which *CN* neurons were silenced, or those in control flies. **i**, Schematics of the functional connectivity among *CN* neurons, IPCs, and AKH-producing cells. Z-stacked projections are shown. \**P* \< *0.05, \*\*P \< 0.01, \*\*\*P \< 0.001;* one-way ANOVA with Tukey post hoc test and unpaired two-tailed t test only for (**d**). See [Supplementary Table 1](#SD5){ref-type="supplementary-material"} for the sample sizes and statistical analyses.](nihms-1540173-f0005){#F5}
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